This study assesses effects of buprenorphine (bup) and naloxone (nal) combinations in decreasing buprenorphine abuse liability. After stabilization, subjects will receive a series of 6 every other day challenge doses: 1) bup/nal placebo; 2)bup/nal (2:1); 3) bup/nal (4:1); 4) bup/nal (8:1); 5) morphine; 6) placebo. Ratings of opiate agonist and antagonist effects will be obtained. Pharmacologic effects of withdrawal following challenge doses are the main outcome measures.
Showing the most recent 10 out of 634 publications